Condition: Psoriatic Arthritis · Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
This study is a marketing-oriented clinical trial of TQH3906 Capsules. A total of 156 participants are planned to be enrolled, aiming to evaluate the dose-effect relationship of TQH3906 versus placebo in the treatment of active Psoriatic Arthritis (PsA) at Week 12, with the proportion of participants achieving an American College of Rheumatology 20% (ACR20) Improvement Criteria (ACR20) response at Week 12 as the primary endpoint.
This description comes directly from the study's public registry record.
Xiaofeng Zeng, Doctor · 13501069845 · xiaofeng.zeng@cstar.org.cn
Always discuss trial participation with your own doctor first.
| Bozhou People's Hospital | Bozhou, Anhui, China | Recruiting |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Southwest Hospital, Third Military Medical University (Army Medical University) | Chongqing, Chongqing Municipality, China | Recruiting |
| Dongguan People's Hospital | Dongguan, Guangdong, China | Recruiting |
| The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | Guangzhou, Guangdong, China | Recruiting |
| The Third Affiliated Hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
| Jiangmen Central Hospital | Jiangmen, Guangdong, China | Recruiting |
| Shenzhen Second People's Hospital | Shenzhen, Guangdong, China | Recruiting |
| The Second Affiliated Hospital of Guangxi Medical University | Nanning, Guangxi, China | Recruiting |
| The Affiliated Hospital of Guizhou Medical University | Guiyang, Guizhou, China | Withdrawn |
| Bao Ding NO.1 Central | Baoding, Hebei, China | Recruiting |
| Hebei Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine | Cangzhou, Hebei, China | Recruiting |
+ 32 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07406035